Home / Drug shortages / Atropine Sulfate Injection

Atropine Sulfate Injection — FDA Drug Shortage

Current — Hikma Pharmaceuticals USA, Inc.

The FDA lists a drug shortage record for Atropine Sulfate Injection (injection) from Hikma Pharmaceuticals USA, Inc. with status Current. The shortage was first posted on 12/20/2023.

Shortage Details

Status
Current
Company
Hikma Pharmaceuticals USA, Inc.
Package NDC
0641-6251-10
Dosage Form
Injection
Presentation
Atropine Sulfate, Injection, 0.4 mg/1 mL (NDC 0641-6251-10)
Initial Posting
12/20/2023
Revised Date

FDA data resources